Thursday, November 19, 2026
Late edition · Updated as it breaks
Log inSubmit a story

“All the news worth catching.”

PaparazziPaparazzi
Top storiesBack PageHow to earnLeaderboard
Catcher tip lineCaught a story first? Earn stock tokens →
Sponsored
Premium projects
DEDeFadePAPackedYour project here
PaparazziPaparazzi

All the news worth catching.

Breaking news on tech, crypto, EVs, e-commerce and social the moment it breaks. Written by AI from verified reporting.

SectionsTop storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & world
EarnStart hereSubmit a storyGTA WeekHow to earnLeaderboardContestsCatcher desksTop catchers by reputationAssignmentsLeagueNews bountiesCityMy catchesRewards
MarketsLive statsProof of payoutsWhale watchDeep Scan token checksStock fundHolder perksRobinhood Chain launchesRobinhood Chain projectsList your projectPremium project pagesPartnersThe Chain Weekly
PaparazziPaparazzi InkPaparazzi Ink top writersOpinionLive coverageEvents calendarThe Back PageSuggest a Back Page storyPaparazzi on TelegramHow it worksFAQProof of workAbout usHow we score trustEditorial policyPrivacy policyCorrectionsRelease notesAdvertiseMedia kitNews APIContact
$PAPA contract · Robinhood Chain
© 2026 Paparazzi

Written by AI from verified reporting. Not financial advice.

  • Home
  • Submit
  • Earn
  • Sign in
Top storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & worldWhales
Health & science
Important· 57

TenK10K maps 5 million immune cells, linking DNA variants to 16 diseases

An Australian-led team built the most detailed map yet of how DNA variants steer immune activity, using single-cell sequencing on nearly 5 million immune cells and the genomes of about 2,000 people. Three studies in Nature tie those variants to 16 autoimmune, neurological and oncological diseases. One variant in natural killer cells points to an unknown route to irritable bowel syndrome. Read more on Paparazzi. Follow for more.

By the Paparazzi desk November 19, 2026 · 9:00 AM · fnob.it · 1 view
Fact boxTrust 50/100 · Developing
What we verified
  • Original source: fnob.it.
  • The source published it on Nov 19, 2026 at 9:00 AM.
What we couldn't
  • No second outlet has reported it yet. Treat it as a single-source claim.

Researchers mapped nearly 5 million immune cells and the genomes of about 2,000 people across three studies published at the same time in Nature. The work, known as the TenK10K project, was led by the Garvan Institute of Medical Research with other Australian centers, and it links DNA variants to 16 diseases spanning autoimmune, neurological and oncological conditions. According to Agenbio, it is the most detailed map yet of how genetic variants shape immune activity.

The breakthrough came from single-cell sequencing. Rather than measuring gene expression across mixed cell populations, the team resolved gene activity one cell at a time. That shift exposed nearly 1,500 genes that contribute to the diseases studied but act only inside specific cell types, making them invisible to conventional methods.

Sponsored

The project traced a full chain: from a genetic variant to the cell type it affects, then to the molecular mechanism, and finally to disease risk. One example stands out. A variant that raises expression of the OSM gene in natural killer cells was tied to a higher risk of irritable bowel syndrome, pointing to an immune pathway that had not been recognized before and could potentially be targeted by drugs.

The stated goal is clinical. Researchers want to use the data to spot, in advance, which patients are most likely to respond to specific therapies based on their genetic and cellular profiles. The findings, published by the Garvan Institute-led team, arrive as three separate papers in Nature.

TopicsGarvan Institute of Medical Research · TenK10K · Nature · OSM gene · natural killer cells · irritable bowel syndrome

Share

Source: fnob.it

Written by AI from verified reporting.

More stories

  • Health & science 12:31 UTC · 17 minutes ago · finance.yahoo.com · 0 views
    Sanofi's next-gen rabies shot VaxRabeo scores EU approval
  • Health & science 11:45 UTC · 1 hour ago · reuters.com · Caught by @mimi💕💕 · 1 view
    AbbVie Bets Up to $2.54B on Disco's Next-Gen Cancer Drugs
  • Health & science 11:12 UTC · 2 hours ago · trtworld.com · Caught by @pz09253 · 0 views
    France lifts bird flu alert to maximum level across mainland
  • Health & science 07:31 UTC · 5 hours ago · news24.com.au · 0 views
    Actinogen trial: Alzheimer's drug slows decline by 30pc in over-75s
Catcher tip line

Caught a story we missed?

Log in and send it in. If it checks out, it runs with your name on it and you earn stock tokens. The bigger the story, the bigger the reward.

Submit a story
The newsletter

Get the paper in your inbox.

A short digest of the biggest news, plus optional breaking alerts. Free, no account needed.